Mika K. Derynck

Director at Enliven Therapeutics · 5 reported transactions in 1 company · latest trade Aug 4, 2026

Their trades


Enliven TherapeuticsELVN	Sold $9.56M · 158,795 shares	Aug 4, 2026	S&P 500 −0.2%thru Oct 28

Aug 4, 2026 · ELVN

$9.56M

S&P 500 −0.2%thru Oct 28

5 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Director at Enliven Therapeutics · 5 reported transactions in 1 company · latest trade Aug 4, 2026


Enliven TherapeuticsELVN	Sold $9.56M · 158,795 shares	Aug 4, 2026	S&P 500 −0.2%thru Oct 28

Aug 4, 2026 · ELVN

$9.56M

S&P 500 −0.2%thru Oct 28

5 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.